Publications
10
Citations
24
Est. group size
~5
Recurring co-author estimate
Active years
45
Publishing since 1982
Kyeongmin Kim's available publication record includes a clinical trial of combination immunotherapy for biliary tract cancer and a zebrafish study of genes involved in Diamond-Blackfan Anemia, a rare blood disorder. The listed OpenAlex topics point to interests in antibody research, protein biology, and muscle/aging physiology, though these show minimal relevance scores in the available data. Overall, the public record is limited, making it hard to characterize a single clear research focus.
Publication activity was absent for most of the last decade but has increased sharply since 2023, rising from 1 paper per year to several in 2025 and 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer
Clinical Cancer Research · 2026
- Unveiling the role of RPS17 and SLC4A1 in diamond-Blackfan Anemia: A zebrafish-based study
Blood Cells Molecules and Diseases · 2025
- Clinical Cancer Research×2
- JCSM Communications×1
- Blood Cells Molecules and Diseases×1
- Pharmaceutics×1
- Cancers×1
- Samuel D. Stimple
Medicine · The Ohio State University
- Bryan Remaily
Medicine · The Ohio State University
- Latha P. Ganesan
Medicine · The Ohio State University
- David W. Wood
Medicine · The Ohio State University
- L.D. Ward
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile